MDXG
NASDAQ · Biotechnology
Mimedx Group Inc
$3.88
-0.09 (-2.27%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+522.4% upside
Low Target
$19.42
Average Target
$24.15
High Target
$35.38
Current Price
$3.88
Current
$3.88
$3.88
Target
$24.15
$24.15
$19.42
$24.15 avg
$35.38
Scenario Analysis
Bear Case
$19.42
400.5%
Low target
Base Case
$24.15
+522.4%
Avg target
Bull Case
$35.38
+811.9%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$7.97
-51.3% from high
52-Week Low
$3.03
+28.1% from low
Target vs 52W High
$24.15
+203.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |